| Clinical characteristics and outcomes of respiratory syncytial virus-associated ARF in immunocompetent patients: A seven-year experience at a tertiary hospital in France D Mokrani, Q Le Hingrat, M Thy, C Choquet, V Joly, S Lariven, C Rioux, ... Journal of Infection 89 (1), 106180, 2024 | | 2024 |
| Correction: COVID-19 associated pulmonary aspergillosis in critically-ill patients: a prospective multicenter study in the era of Delta and Omicron variants P Bay, E Audureau, S Préau, R Favory, A Guigon, N Heming, E Gault, ... Annals of Intensive Care 14 (1), 87, 2024 | | 2024 |
| ESTIVaRS–Estimation du fardeau des hospitalisations dues au Virus Respiratoire Syncytial chez les adultes âgés en France S Marot, T Cocherie, N Hourou, C Charpentier, A Marcelin, D Descamps, ... Médecine et Maladies Infectieuses Formation 3 (2), S65, 2024 | | 2024 |
| RSV-GenoScan: An automated pipeline for whole-genome human respiratory syncytial virus (RSV) sequence analysis A Dosbaa, R Guilbaud, AMF Yusti, VM Ferré, C Charpentier, D Descamps, ... Journal of Virological Methods 327, 114938, 2024 | | 2024 |
| Characteristics and outcomes of COVID-19 patients admitted to hospital with and without respiratory symptoms BW Citarella, C Kartsonaki, ED Ibánez-Prada, BP Gonçalves, J Baruch, ... Heliyon 10 (10), 2024 | | 2024 |
| In vitro phenotypic susceptibility of HIV-1 non-group M to CCR5 inhibitor (maraviroc): TROPI-CO study S Gracias, I El Yaalaoui, B Visseaux, C Charpentier, D Descamps, ... Microbiology Spectrum, e03895-23, 2024 | | 2024 |
| Pharmaco-virological Outcomes and Genotypic Resistance Profiles Among Children and Adolescents Receiving a Dolutegravir (DTG)-Based Regimen in Togo YR Konu, E Takassi, G Peytavin, N Dapam, F Damond, WA Oumarou, ... Clinical Infectious Diseases, ciae278, 2024 | | 2024 |
| Prevalence of pretreatment HIV resistance to integrase inhibitors in West African and Southeast Asian countries AF Aghokeng, N Ngo-Giang-Huong, THK Huynh, AY Dagnra, ... Journal of Antimicrobial Chemotherapy 79 (5), 1164-1168, 2024 | | 2024 |
| COVID-19 associated pulmonary aspergillosis in critically-ill patients: a prospective multicenter study in the era of Delta and Omicron variants P Bay, É Audureau, S Préau, R Favory, A Guigon, N Heming, E Gault, ... Annals of Intensive Care 14 (1), 65, 2024 | 1 | 2024 |
| Salvage Therapy Including Foscarnet and Ibalizumab for Multidrug-Resistant Human Immunodeficiency Virus Type 2 Infection A Bachelard, Q Le Hingrat, VM Ferré, M Lê, G Peytavin, F Damond, ... Clinical Infectious Diseases 78 (4), 1005-1010, 2024 | | 2024 |
| Higher levels of SARS-CoV-2 genetic variation in immunocompromised patients: a retrospective case-control study R Guilbaud, AM Franco Yusti, V Leducq, K Zafilaza, A Bridier-Nahmias, ... The Journal of Infectious Diseases 229 (4), 1041-1049, 2024 | 2 | 2024 |
| BA. 2.86 variant emergence and spread dynamics through wastewater monitoring in Paris, France S Wurtzer, R Guilbaud, M Levert, N Fagour, Q Le Hingrat, D Descamps, ... Science of The Total Environment 917, 170355, 2024 | | 2024 |
| Real-world data on commercial long-acting intramuscular maintenance therapy with cabotegravir and rilpivirine mirror phase 3 results: Findings from a University Hospital in … VM Ferre, A Serris, Q Le Hingrat, A Bachelard, C Charpentier, ... HIV MEDICINE 24, 160-161, 2023 | | 2023 |
| 3-Year analysis of emergent resistance-associated mutations at first-or second-line HIV-1 virologic failure with second generation INSTIs in 2-and 3-drug regimens (Virostar study) AG Marcelin, C Soulié, M Wirden, C Charpentier, D Descamps, V Calvez HIV MEDICINE 24, 373-374, 2023 | | 2023 |
| Implementation of Recommendations on the Use of Corticosteroids in Severe COVID-19 F Camirand-Lemyre, L Merson, BKT Vijayaraghavan, AJC Burrell, ... JAMA Network Open 6 (12), e2346502-e2346502, 2023 | 1 | 2023 |
| Proportion of APOBEC3-induced defective HIV DNA after 1 year of dolutegravir+ lamivudine simplification in the ANRS 167 LAMIDOL trial F Mazouz, M Bertine, R Coppée, A Storto, C Katlama, R Landman, ... Journal of Antimicrobial Chemotherapy 78 (12), 2995-3002, 2023 | | 2023 |
| High sera levels of SARS‐CoV‐2 N antigen are associated with death in hospitalized COVID‐19 patients HR Chenane, G Lingas, R Menidjel, C Laouenan, S Tubiana, ... Journal of Medical Virology 95 (11), e29247, 2023 | | 2023 |
| Recommendations on data sharing in HIV drug resistance research SC Inzaule, MJ Siedner, SJ Little, S Avila-Rios, A Ayitewala, RJ Bosch, ... PLoS medicine 20 (9), e1004293, 2023 | | 2023 |
| Recommendations on data sharing in HIV drug resistance research. S Avila-Rios, A Ayitewala, R Bosch, V Calvez, F Ceccherini-Silberstein, ... PLoS Medicine 20 (9), 2023 | | 2023 |
| Hépatites B et C chez les adolescents de la rue au Togo en 2021: prévalence et profil vaccinal AJ Sadio, HR Kouanfack, AC Dagnra, AP Amenyah-Ehlan, VM Ferré, ... Revue d'Épidémiologie et de Santé Publique 71, 101917, 2023 | | 2023 |
